News from Zyme and the companies we work with.

June 19, 18

Enamine and TBD Biodiscovery collaborate to provide GMP-based services

Collaboration combines expertise in novel chemical compound synthesis with GMP manufacture in drug discovery  Kiev, Ukraine, and Tartu, Estonia, June 19th 2018. Enamine Ltd., a chemical research organization and producer of novel building blocks and screening libraries, and TBD Biodiscovery, … Continue reading →

June 13, 18

Mologic and Newcastle University launch BReD diagnostic for blackgrass resistance at Cereals

Rapid, one-step, lateral flow test for real-time detection of herbicide resistance in blackgrass Bedfordshire and Newcastle, UK, 13 June 2018:    Mologic Ltd, a developer of personalised diagnostics, and Newcastle University, today announced they have developed an on-farm blackgrass resistance diagnostic … Continue reading →

June 11, 18

Avacta Group plc announces the appointment of Dr Eliot Forster as Non-Executive Chairman

Highly experienced pharma/biotech professional to lead Avacta’s Board Wetherby and Cambridge, UK, 11 June 2018:   Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce the appointment of Dr Eliot Forster as Non-Executive Chairman to the … Continue reading →

June 9, 18

Dr Darrin M Disley Awarded OBE

Recognises achievement in the advancement of the UK life science industry and the support of student entrepreneurs and their businesses Cambridge, UK, 09 June 2018: Scientist, entrepreneur and enterprise champion, Dr Darrin M Disley has been appointed an Officer of the … Continue reading →

June 5, 18

IONTAS signs collaboration agreement with LG Chem, Ltd. to identify therapeutic oncology leads

Cambridge, UK and Seoul, Korea, 05 June 2018: IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, today announced it has signed a collaboration agreement with Korean-based LG Chem, Ltd. for the discovery of therapeutic … Continue reading →

June 5, 18

Fujifilm completes acquisition of Irvine Scientific Sales Company and IS Japan, leading companies of cell culture media

SANTA ANA, California 05 June, 2018: FUJIFILM Corporation (President: Kenji Sukeno) announced today that it has completed the acquisition of Irvine Scientific Sales Company, Inc. (ISUS) and IS JAPAN CO.,LTD. (ISJ), leading companies in cell culture media for about US$800 … Continue reading →

June 4, 18

New REAL Space Navigator Breaks Billion Compound Barrier

Enamine and BioSolveIT collaboration exceeds expectations to deliver 3.8bn new compounds on demand Kiev, Ukraine, and Sankt Augustin, Germany, 04 June 2018. Enamine Ltd., a leading compound supplier and BioSolveIT GmbH, a premium provider of drug discovery software, today announced the availability … Continue reading →

May 30, 18

IONTAS awarded £556K ($737K) from Innovate UK to develop therapies for chronic pain management

Funding will be used to further develop IONTAS’ ion-channel targeting KnotBody antibody platform to block pain transmission via Nav1.7 Cambridge, UK, 30 May 2018: IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, announced today … Continue reading →

May 24, 18

Bio-Rad Launches a Range of Anti-idiotypic Antibodies Targeting Pembrolizumab and Nivolumab

HERCULES, Calif.–May 24, 2018–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of a range of anti-idiotypic antibodies targeting the immune checkpoint inhibitor drugs: pembrolizumab (Keytruda) and … Continue reading →

May 22, 18

Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT Biotech

Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits Wetherby and Cambridge, UK, 22 May 2018:   Avacta Group plc (AIM: AVCT), the developer of Affimer®biotherapeutics and reagents, is pleased to announce that its … Continue reading →